tiprankstipranks
Perspective Therapeutics (DE:AAJ0)
FRANKFURT:AAJ0
Germany Market

Perspective Therapeutics (AAJ0) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
2Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Perspective Therapeutics’s (AAJ0) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Perspective Therapeutics is a Sell.
Perspective Therapeutics’s (AAJ0) 20-Day exponential moving average is 2.67, while Perspective Therapeutics’s (AAJ0) share price is €2.38, making it a Buy.
Perspective Therapeutics’s (AAJ0) 50-Day exponential moving average is 2.72, while Perspective Therapeutics’s (AAJ0) share price is €2.38, making it a Buy.

Perspective Therapeutics (AAJ0) Pivot Points

Aug 25, 2026, 05:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.88
2.88
2.88
2.88
2.88
2.88
2.88
Fibonacci
2.88
2.88
2.88
2.88
2.88
2.88
2.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Perspective Therapeutics (AAJ0) Moving Averages

Aug 25, 2026, 05:04 AM
Period
Simple
Exponential
MA5
2.79Buy
2.83Buy
MA10
2.69Buy
2.74Buy
MA20
2.60Buy
2.67Buy
MA50
2.64Buy
2.72Buy
MA100
2.98Buy
2.88Buy
MA200
2.96Buy
2.85Buy
Perspective Therapeutics’s (AAJ0) 10-Day exponential moving average is 2.74, while Perspective Therapeutics’s (AAJ0) share price is €2.38, making it a Buy.
Perspective Therapeutics’s (AAJ0) 100-Day exponential moving average is 2.88, while Perspective Therapeutics’s (AAJ0) share price is €2.38, making it a Buy.
Perspective Therapeutics’s (AAJ0) stock price is €2.38 and Perspective Therapeutics’s (AAJ0) 50-day simple moving average is 2.64, creating a Buy signal.
Perspective Therapeutics’s (AAJ0) stock price is €2.38 and Perspective Therapeutics’s (AAJ0) 100-day simple moving average is 2.98, creating a Buy signal.
Perspective Therapeutics’s (AAJ0) stock price is €2.38 and Perspective Therapeutics’s (AAJ0) 200-day simple moving average is 2.96, creating a Buy signal.

Perspective Therapeutics (AAJ0) Technical Indicators

Aug 25, 2026, 05:04 AM
Name
Value
Implied Action
RSI (14)
63.73
Neutral
STOCH (9,6)
93.38
Sell
STOCHRSI (14)
92.88
Sell
MACD (12,26)
0.05
Sell
ADX (14)
20.09
Neutral
CCI (14)
173.21
Sell
ATR (14)
0.13
-
Ultimate Oscillator
76.59
Buy
ROC
15.17
Buy
Bull/Bear Power (13)
0.25
Buy
Perspective Therapeutics’s (AAJ0) Relative Strength Index (RSI) is 63.73, creating a Neutral signal.
Perspective Therapeutics’s (AAJ0) Trend Strength Indicator (ADX) is 20.09, creating a Neutral signal.
Perspective Therapeutics’s (AAJ0) Commodity Channel Index (CCI) is 173.21, creating a Sell signal.
Perspective Therapeutics’s (AAJ0) Price Rate of Change (ROC) is 15.17, creating a Buy signal.

FAQ

Is AAJ0 a Buy, Hold, or Sell?
Based on AAJ0’s technical indicators, AAJ0 is a Strong Buy.
    What is AAJ0’s RSI (14)?
    AAJ0’s RSI (14) is 63.73, which suggests AAJ0 is a Neutral.
      What is AAJ0’s MACD?
      AAJ0’s MACD is 0.05, which suggests AAJ0 is a Sell.
        What is AAJ0’s 5-day moving average?
        AAJ0’s 5-day moving average is 2.79, which suggests AAJ0 is a Buy.
          What is AAJ0’s 20-day moving average?
          AAJ0 20-day moving average is 2.60, which suggests AAJ0 is a Buy.
            What is AAJ0’s 50-day moving average?
            AAJ0’s 50-day moving average is 2.64, which suggests AAJ0 is a Buy.
              What is AAJ0’s 200-day moving average?
              AAJ0’s 200-day moving average is 2.96, which suggests AAJ0 is a Buy.
                What is AAJ0’s Williams % R (14)?
                AAJ0’s Williams % R (14) is 0.00, which suggests AAJ0 is a Buy.
                  What is AAJ0’s CCI (14)?
                  AAJ0’s CCI (14) is 173.21, which suggests AAJ0 is a Sell.
                    What is the share price of Perspective Therapeutics?